RE:RE:RE:New ArticleAggrastat's net realized price to MPH will likely decrease over the next 12-24 months by 50%-75%. Contracts with US hospitals are typically for one year and that is for pricing. If an alternative is offered, they can just stop buying. There are no volume guarantees..period
Zypitimag was purchased for several million dollars although looking a their last few cash flow statements it does not appear that the scheduled payments are being made to the Company that sold it to them...they could lose this drug due to this anytime.
Friesen has no issues buying shares...A CEO AND a PRES. together making 500K a year....for what exactly? Usually there is one person in this role, and even successful biotechs, the compensation is way less. He is buying shares with shareholder money paid to him...for losing massive amounts of money for years. Great gig if you can swing it. LOL Again, See my prior post...shareholders will get screwed IMO